Clinical Trial Update: Metabolic Radiotherapy After Complete Resection of Liver Metastases in Patient With Digestive Neuroendocrine Tumor [Phase 3]

View source ↗

Summary

Phase 3 trial investigating metabolic radiotherapy after complete resection of liver metastases in digestive neuroendocrine tumor was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive Neuroendocrine Tumor
• Liver Metastases

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Digestive Neuroendocrine Tumors, Metabolic Radiotherapy | Phase 3 | Status: TERMINATED